Determination of grepafloxacin and clinafloxacin by capillary zone electrophoresis.

J Chromatogr B Analyt Technol Biomed Life Sci

Department of Analytical Chemistry, Faculty of Sciences, University of Granada, Avda. Fuentenueva s/n, E-18071 Granada, Spain.

Published: May 2002

A simple and rapid capillary zone electrophoresis determination method with UV detection of grepafloxacin and clinafloxacin has been developed. The separation was performed in 35 mM borate-35 mM phosphate buffer solution (pH 8.6), containing 6% (v/v) of acetonitrile. Analyses were realised using fused-silica capillaries (57 cm length x 75 microm I.D.) and the operating conditions were: 15 kV applied voltage, 30 degrees C and detection at 279 nm. Piromidic acid was used as an internal standard. The linear concentration range of application was 1.0-120.0 microg ml(-1) for both compounds, with a detection limit of 0.2 microg ml(-1) for grepafloxacin and 0.3 microg ml(-1) for clinafloxacin. The analysis yielded good reproducibility (RSD between 3.37 and 1.74%). It was applied to the determination of grepafloxacin and clinafloxacin in human and rat urine samples. The method was validated using HPLC as a reference method. Recovery levels were between 94.5 and 103%.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1570-0232(02)00050-8DOI Listing

Publication Analysis

Top Keywords

grepafloxacin clinafloxacin
12
microg ml-1
12
determination grepafloxacin
8
capillary zone
8
zone electrophoresis
8
clinafloxacin
4
clinafloxacin capillary
4
electrophoresis simple
4
simple rapid
4
rapid capillary
4

Similar Publications

Fluoroquinolones, the cornerstone of treatment of drug-resistant tuberculosis: a pharmacokinetic and pharmacodynamic approach.

Curr Pharm Des

March 2012

Department of Hospital and Clinical pharmacy, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Fluoroquinolones (FQs) are important drugs to treat drug-resistant tuberculosis. In this review we integrated pharmacokinetic properties (PK) and microbiological susceptibility against M. tuberculosis and eventually evaluated the pharmcodynamic (PD) properties, as well as the influence of co-administered agents on these characteristics, for the currently used FQs (ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin and moxifloxacin) in TB treatment.

View Article and Find Full Text PDF

The role of quinolones in chronic obstructive pulmonary disease.

Curr Opin Infect Dis

December 1999

Department of Respiratory Medicine, Birmingham Heartlands Hospital, Bordesley Green East, Birmingham, UK.

Chronic obstructive pulmonary disease is a disease state characterized by the presence of airflow obstruction due to chronic bronchitis and/or emphysema. The airflow obstruction is generally progressive. In the past asthma was often confused with chronic obstructive pulmonary disease but as the cellular inflammatory mechanisms are quite different to chronic bronchitis and emphysema it is prudent to separate this condition of airway hyper-responsiveness.

View Article and Find Full Text PDF

Mutagenesis induced by 12 quinolone antibacterial agents in Escherichia coli WP2uvrA/pKM101.

Toxicol In Vitro

April 2006

Drug Safety Research Laboratory, R and D Division, Daiichi Pharmaceutical Co., Ltd., 16-13 Kita-Kasai 1-Chome, Edogawa-ku, Tokyo 134-8630, Japan.

The mutagenic potential of 12 quinolone antibacterial agents (quinolones) was examined at concentrations of 3.91-1000 ng/plate with or without S9 mix in Escherichia coli WP2uvrA/pKM101. All quinolones showed mutagenic potential in the strain: the maximum numbers of revertant colonies were observed at 7.

View Article and Find Full Text PDF

Therapeutic advances of new fluoroquinolones.

Expert Opin Investig Drugs

May 1998

University of St. Andrews, Fife, KY16 8XU, Scotland.

Fluoroquinolone antimicrobials have been available for over 10 years. Recent modifications to nuclear side-chains have enhanced both the antimicrobial and pharmacokinetic profiles of this class. Rapidly increasing antimicrobial resistance among community and hospital bacterial pathogens has diminished therapeutic options.

View Article and Find Full Text PDF
Article Synopsis
  • A total of 6,991 unique patient isolates of Streptococcus pneumoniae were collected in Canada from 1997 to 2002, revealing that 20.2% were penicillin nonsusceptible, with a notable increase in high-level penicillin resistance over the years.
  • The study found rising resistance rates to non-beta-lactam antibiotics, particularly among penicillin-resistant strains, while no resistance to vancomycin or linezolid was detected.
  • Despite a reduction in overall antibiotic usage, the rates of multidrug-resistant and high-level penicillin-resistant S. pneumoniae are still on the rise in Canada.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!